{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"Scribe secures $129M in a rare gene editing IPO","author_name":"techandbusiness.org · Startups","thumbnail_url":"https://imgproxy.divecdn.com/zARXwXqvhh1VyKwjxrIXUGmwSp5Vq4cO8LXq9WaHn0s/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTU2MTc2MTM5LmpwZw==.webp","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · Startups</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/AtetyUquEgBgQFnibcMScd\" style=\"color:#fff;text-decoration:none;\">Scribe secures $129M in a rare gene editing IPO</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">Scribe Therapeutics priced an initial public offering on July 23, 2026, raising close to $129 million in the first IPO for a gene editing company in more than two years, BioPharma Dive reported. The s...</p>\n    </blockquote>"}